Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

In 1999, the average list price of Humalog—a brand-name insulin medication manufactured by Eli Lilly—was only $21." "By 2017, the list price of Humalog soared to more than $274—a staggering ...